The Recall Desk
ModerateFDA (Drugs)·D-1740-2019·Announced 2019-08-21

US Pharmaceuticals Recalls Wonder Freeze Pain Gel Due to Water Quality Issues

US Pharmaceuticals is recalling Wonder Freeze Pain Relieving Gel because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The hazard involves manufacturing deviations in water quality rather than a confirmed high-risk pathogen or injury report, fitting the Moderate severity criteria for low-risk contamination or voluntary precautionary measures.

Plain-English summary

US Pharmaceuticals Inc. is recalling Wonder Freeze Pain Relieving Gel with ILEX, Menthol 5%. The recall affects 147 cases of the product in 3 oz, 4 oz, and 16 oz packages, which were distributed nationwide in the USA.

The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the purified water utilized in the manufacturing process yielded out-of-specification results for either total microbial count or total organic carbon.

Consumers who have purchased this product should check their lot numbers and expiration dates against the specific lots identified in the recall notice. If the product matches the recalled lots, consumers should stop using it and contact the manufacturer for further instructions.

The recalled product

Product
Wonder Freeze Pain Releiving Gel with ILEX, Menthol 5%, packaged in a) 3 OZ /85 g (UPC 0 99528 35903 5); b) 4 OZ / 113 g (UPC 0 99528 31504 8); c) 16 OZ / 454 g (UPC 0 99528 31516 1); Manufactured For: Wonder Laboratories, 115 S.C.T. Ct., White House TN. 37188.
Affected units
147

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Lot # a) 21J18
  • EXP 07/2021 b) 42H18
  • EXP 06/2021
  • c) 32H18
  • EXP 6/2021

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 18 recalled by US Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 18 products in this recall →